Cardiac evaluation prior to kidney transplantation

Rowena B. Delos Santos, Aleksandra Gmurczyk, Jagdeep S. Obhrai, Suzanne Watnick

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Kidney transplantation is the treatment of choice for most patients with stage 5 chronic kidney disease and end-stage renal disease (ESRD), offering improved quality of life and overall survival rates. However, the limited supply of available organs makes this a scarce resource. Cardiovascular complications continue to be the leading cause of mortality in the kidney transplant population, accounting for over 30% of deaths with a functioning allograft. Thus, preoperative cardiac risk assessment is critical to optimize patient selection and outcomes. Currently there is no consensus for cardiovascular evaluation in the chronic kidney disease and ESRD population prior to kidney transplantation; the recommendations of the American Society of Nephrology and American Society of Transplantation differ from those of the American Heart Association and the American College of Cardiology. Previously developed risk scores have also been used to risk stratify this population. In this review, we discuss two cases that illustrate the difficulties of interpreting the prognostic value of current testing strategies. We also discuss the importance of different tests for cardiovascular evaluation as well as previous nonkidney transplant specific risk scores used in the pre-kidney transplant population.

Original languageEnglish (US)
Pages (from-to)324-329
Number of pages6
JournalSeminars in Dialysis
Volume23
Issue number3
DOIs
StatePublished - May 2010

Fingerprint

Kidney Transplantation
Transplants
Chronic Renal Insufficiency
Population
Chronic Kidney Failure
Kidney
Patient Selection
Allografts
Survival Rate
Quality of Life
Mortality
Therapeutics

ASJC Scopus subject areas

  • Nephrology
  • Medicine(all)

Cite this

Delos Santos, R. B., Gmurczyk, A., Obhrai, J. S., & Watnick, S. (2010). Cardiac evaluation prior to kidney transplantation. Seminars in Dialysis, 23(3), 324-329. https://doi.org/10.1111/j.1525-139X.2010.00725.x

Cardiac evaluation prior to kidney transplantation. / Delos Santos, Rowena B.; Gmurczyk, Aleksandra; Obhrai, Jagdeep S.; Watnick, Suzanne.

In: Seminars in Dialysis, Vol. 23, No. 3, 05.2010, p. 324-329.

Research output: Contribution to journalArticle

Delos Santos, RB, Gmurczyk, A, Obhrai, JS & Watnick, S 2010, 'Cardiac evaluation prior to kidney transplantation', Seminars in Dialysis, vol. 23, no. 3, pp. 324-329. https://doi.org/10.1111/j.1525-139X.2010.00725.x
Delos Santos RB, Gmurczyk A, Obhrai JS, Watnick S. Cardiac evaluation prior to kidney transplantation. Seminars in Dialysis. 2010 May;23(3):324-329. https://doi.org/10.1111/j.1525-139X.2010.00725.x
Delos Santos, Rowena B. ; Gmurczyk, Aleksandra ; Obhrai, Jagdeep S. ; Watnick, Suzanne. / Cardiac evaluation prior to kidney transplantation. In: Seminars in Dialysis. 2010 ; Vol. 23, No. 3. pp. 324-329.
@article{f686b0c8e18746549502cd7696327807,
title = "Cardiac evaluation prior to kidney transplantation",
abstract = "Kidney transplantation is the treatment of choice for most patients with stage 5 chronic kidney disease and end-stage renal disease (ESRD), offering improved quality of life and overall survival rates. However, the limited supply of available organs makes this a scarce resource. Cardiovascular complications continue to be the leading cause of mortality in the kidney transplant population, accounting for over 30{\%} of deaths with a functioning allograft. Thus, preoperative cardiac risk assessment is critical to optimize patient selection and outcomes. Currently there is no consensus for cardiovascular evaluation in the chronic kidney disease and ESRD population prior to kidney transplantation; the recommendations of the American Society of Nephrology and American Society of Transplantation differ from those of the American Heart Association and the American College of Cardiology. Previously developed risk scores have also been used to risk stratify this population. In this review, we discuss two cases that illustrate the difficulties of interpreting the prognostic value of current testing strategies. We also discuss the importance of different tests for cardiovascular evaluation as well as previous nonkidney transplant specific risk scores used in the pre-kidney transplant population.",
author = "{Delos Santos}, {Rowena B.} and Aleksandra Gmurczyk and Obhrai, {Jagdeep S.} and Suzanne Watnick",
year = "2010",
month = "5",
doi = "10.1111/j.1525-139X.2010.00725.x",
language = "English (US)",
volume = "23",
pages = "324--329",
journal = "Seminars in Dialysis",
issn = "0894-0959",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Cardiac evaluation prior to kidney transplantation

AU - Delos Santos, Rowena B.

AU - Gmurczyk, Aleksandra

AU - Obhrai, Jagdeep S.

AU - Watnick, Suzanne

PY - 2010/5

Y1 - 2010/5

N2 - Kidney transplantation is the treatment of choice for most patients with stage 5 chronic kidney disease and end-stage renal disease (ESRD), offering improved quality of life and overall survival rates. However, the limited supply of available organs makes this a scarce resource. Cardiovascular complications continue to be the leading cause of mortality in the kidney transplant population, accounting for over 30% of deaths with a functioning allograft. Thus, preoperative cardiac risk assessment is critical to optimize patient selection and outcomes. Currently there is no consensus for cardiovascular evaluation in the chronic kidney disease and ESRD population prior to kidney transplantation; the recommendations of the American Society of Nephrology and American Society of Transplantation differ from those of the American Heart Association and the American College of Cardiology. Previously developed risk scores have also been used to risk stratify this population. In this review, we discuss two cases that illustrate the difficulties of interpreting the prognostic value of current testing strategies. We also discuss the importance of different tests for cardiovascular evaluation as well as previous nonkidney transplant specific risk scores used in the pre-kidney transplant population.

AB - Kidney transplantation is the treatment of choice for most patients with stage 5 chronic kidney disease and end-stage renal disease (ESRD), offering improved quality of life and overall survival rates. However, the limited supply of available organs makes this a scarce resource. Cardiovascular complications continue to be the leading cause of mortality in the kidney transplant population, accounting for over 30% of deaths with a functioning allograft. Thus, preoperative cardiac risk assessment is critical to optimize patient selection and outcomes. Currently there is no consensus for cardiovascular evaluation in the chronic kidney disease and ESRD population prior to kidney transplantation; the recommendations of the American Society of Nephrology and American Society of Transplantation differ from those of the American Heart Association and the American College of Cardiology. Previously developed risk scores have also been used to risk stratify this population. In this review, we discuss two cases that illustrate the difficulties of interpreting the prognostic value of current testing strategies. We also discuss the importance of different tests for cardiovascular evaluation as well as previous nonkidney transplant specific risk scores used in the pre-kidney transplant population.

UR - http://www.scopus.com/inward/record.url?scp=77955163568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955163568&partnerID=8YFLogxK

U2 - 10.1111/j.1525-139X.2010.00725.x

DO - 10.1111/j.1525-139X.2010.00725.x

M3 - Article

C2 - 20636926

AN - SCOPUS:77955163568

VL - 23

SP - 324

EP - 329

JO - Seminars in Dialysis

JF - Seminars in Dialysis

SN - 0894-0959

IS - 3

ER -